CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-07 | Reeve Emma Director | Grant or award · Stock Option (Right To Buy) | +12,000 | 12,000 | ||
| 2022-01-07 | Okey Stephanie Director | Grant or award | +3,200 | 4,163 | ||
| 2022-01-07 | Okey Stephanie Director | Grant or award · Stock Option (Right To Buy) | +12,000 | 12,000 | ||
| 2022-01-07 | ZELDIS JEROME B Director | Grant or award | +3,200 | 6,500 | ||
| 2022-01-07 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right To Buy) | +12,000 | 12,000 | ||
| 2022-01-07 | SOUTHWELL DAVID P Director | Grant or award | +3,200 | 6,500 | ||
| 2022-01-07 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right To Buy) | +12,000 | 12,000 | ||
| 2022-01-07 | STEELE GLENN JR MD PHD Director | Grant or award | +3,200 | 6,500 | ||
| 2022-01-07 | STEELE GLENN JR MD PHD Director | Grant or award · Stock Option (Right To Buy) | +12,000 | 12,000 | ||
| 2022-01-04 | Almstead Neil Gregory Chief Technical Ops Officer | Sale | −64 | $41.16 | $3K | 1,755 |
| 2022-01-04 | Hill Emily Luisa Chief Financial Officer | Sale | −173 | $41.16 | $7K | 23,133 |
| 2022-01-04 | Pauwels Eric Chief Business Officer | Sale | −806 | $41.16 | $33K | 35,386 |
| 2022-01-04 | Peltz Stuart Walter Chief Executive Officer | Sale | −378 | $41.16 | $16K | 22,834 |
| 2021-09-02 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion | +3,363 | $18.01 | $61K | 51,737 |
| 2021-09-02 | Boulding Mark Elliott Exec. VP and CLO | Sale | −3,363 | $45.01 | $151K | 48,374 |
| 2021-09-02 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −3,363 | $18.01 | $61K | 15,653 |
| 2021-08-13 | Okey Stephanie Director | Sale | −1,650 | $40.06 | $66K | 963 |
| 2021-07-09 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion | +548 | $18.01 | $10K | 48,922 |
| 2021-07-09 | Boulding Mark Elliott Exec. VP and CLO | Sale | −548 | $45.00 | $25K | 48,374 |
| 2021-07-09 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion | +410 | $18.01 | $7K | 48,784 |
Page 50 of 53 · 1,049 trades